Freshpet (FRPT) Cash & Equivalents (2012 - 2026)

Freshpet (FRPT) has 15 years of Cash & Equivalents data on file, last reported at $381.4 million in Q1 2026.

• For the quarter ending Q1 2026, Cash & Equivalents rose 56.48% year-over-year to $381.4 million; the trailing twelve-month figure through Mar 2026 stood at $381.4 million (up 56.48% YoY), and the FY2025 full-year result was $278.0 million, up 3.48% from the prior year.
• Cash & Equivalents improved to $381.4 million in Q1 2026, from $278.0 million in the prior quarter.
• In the past five years, Cash & Equivalents ranged from a high of $381.4 million in Q1 2026 to a low of $29.7 million in Q1 2022.
• A 5-year average of $258.9 million and a median of $268.6 million in 2024 frame the typical range for Cash & Equivalents.
• Across the five-year window, Cash & Equivalents slumped 91.28% in 2022 and jumped 1034.02% in 2023, its largest moves.
• Tracing FRPT's Cash & Equivalents over 5 years: stood at $132.7 million in 2022, then surged by 123.66% to $296.9 million in 2023, then declined by 9.51% to $268.6 million in 2024, then rose by 3.48% to $278.0 million in 2025, then jumped by 37.2% to $381.4 million in 2026.
• Business Quant data shows FRPT's Cash & Equivalents at $381.4 million in Q1 2026, $278.0 million in Q4 2025, and $274.6 million in Q3 2025.